Long Xiang-Ju, Lin Shan, Sun Ya-Nan, Zheng Zhen-Feng
Department of Nephrology, First Affiliated Hospital of Tianjin Medical University, Tianjin, China.
Asian Pac J Cancer Prev. 2012;13(8):4097-100. doi: 10.7314/apjcp.2012.13.8.4097.
BACKGROUND/AIMS: Diabetes mellitus (DM) is widely considered to be associated with risk of cancer, but studies investigating the association between DM and prostate cancer in Asian countries have reported inconsistent findings. We examined this association by conducting a detailed meta-analysis of studies published on the subject.
Cohort or case-control studies were identified by searching Pubmed, Embase and Wanfang databases through May 30, 2012. Pooled relative risk (RR) with its corresponding 95% confidence interval (95% CI) were calculated using the random-effects model. Subgroup analyses were performed by the study type.
Finally, we identified 7 studies (four cohort studies and three case-control studies) with a total of 1,751,274 subjects from Asians. DM was associated with an increased risk of prostate cancer in Asians (unadjusted RR= 2.82, 95% CI 1.73-4.58, P < 0.001; adjusted RR= 1.31, 95% CI 1.12-1.54, P = 0.001). Subgroup analyses by study design further confirmed an obvious association.
Findings from this meta-analysis strongly support that diabetes is associated with an increased risk of prostate cancer in Asians.
背景/目的:糖尿病(DM)被广泛认为与癌症风险相关,但在亚洲国家,关于DM与前列腺癌之间关联的研究报告结果并不一致。我们通过对该主题已发表的研究进行详细的荟萃分析来研究这种关联。
通过检索截至2012年5月30日的PubMed、Embase和万方数据库来确定队列研究或病例对照研究。使用随机效应模型计算合并相对风险(RR)及其相应的95%置信区间(95%CI)。按研究类型进行亚组分析。
最终,我们确定了7项研究(4项队列研究和3项病例对照研究),共纳入1,751,274名亚洲受试者。DM与亚洲人患前列腺癌风险增加相关(未调整RR = 2.82,95%CI 1.73 - 4.58,P < 0.001;调整后RR = 1.31,95%CI 1.12 - 1.54,P = 0.001)。按研究设计进行的亚组分析进一步证实了这种明显的关联。
这项荟萃分析的结果有力地支持了糖尿病与亚洲人患前列腺癌风险增加相关这一观点。